Product Name:

MAPKAPK5-pT186


Product Number:

ab-pk693

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: MAP kinase-activated protein kinase 5

Target Alias: MAP kinase-activated protein kinase 5; MAPKAP kinase 5; PRAK

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK693

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: T186

Protein UniProt: Q8IW41

Protein SigNET: Q8IW41

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human MAPKAPK5 (PRAK) sequence peptide Cat. No.: PE-04AAS95

Antibody Immunogen Sequence: PQF(pT)PYYV(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues P183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.

Production Method: Corresponds to amino acid residues P183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Strong immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 53-58 kDa.

Antibody Specificity: Very high

Scientific Background: MAPKAPK5 is a protein-serine/threonine kinase of the CAMK group and MAPKAPK family. p38 alpha and beta-dependent phosphorylation increases its activity. It is activated by stress-related extracellular stimuli; such as H2O2, arsenite, anisomycin TNF alpha and also PMA and the calcium ionophore A23187; but to a lesser extent. In vitro, activated by SQSTM1. T182A substitution leads to no p38-beta/MAPK11-induced activation. In addition, T182D, S212D and L337G mutations are associated with higher protein kinase activity. It appears to be a tumour suppressor protein (TSP) that mediates Ras-induced senescence and phosphorylates p53/TP53. It also phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, and RHEB.